Extended Data Fig. 9: Tumor board discussions of cases with discrepant classification. | Nature Medicine

Extended Data Fig. 9: Tumor board discussions of cases with discrepant classification.

From: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

Extended Data Fig. 9: Tumor board discussions of cases with discrepant classification.The alternative text for this image may have been generated using AI.

Details of tumor board discussions of tumors with discrepant classification by random forest (RF)-based and t-SNE-based DNA methylation class assignment (as in Fig. 3c and Supplementary Fig. 8; upper two rows) and WHO-based tumor type (third row). Colors in rows 1–3 correspond to tumor types and classes as indicated in Fig. 1 and Extended Data Fig. 1. Tumor board participants and availability of additional information (gene panel sequencing, reference radiology) is indicated by black boxes as well as compatibility with DNA methylation- and WHO-based tumor classification. Levels of discrepancy (corresponding to Fig. 3c and Supplementary Fig. 8) and tumor board consensus are categorized in bottom rows. See Supplementary Table 1 for underlying data.

Back to article page